Nemattalab M, Shenagari M, Taheri M, Mahjoob M, Nazari Chamaki F, Mojtahedi A, et al. Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice. Cytokine. 2020;126:154866 pubmed publisher

Dobrica M, Lazar C, Paruch L, van Eerde A, Clarke J, Tucureanu C, et al. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice. Vaccine. 2018;36:5789-5795 pubmed publisher

Dobrica M, Lazar C, Paruch L, Skomedal H, Steen H, Haugslien S, et al. A novel chimeric Hepatitis B virus S/preS1 antigen produced in mammalian and plant cells elicits stronger humoral and cellular immune response than the standard vaccine-constituent, S protein. Antiviral Res. 2017;144:256-265 pubmed publisher

Altenburg A, Magnusson S, Bosman F, Stertman L, de Vries R, Rimmelzwaan G. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice. Clin Exp Immunol. 2017;190:19-28 pubmed publisher

Stavaru C, Onu A, Lupulescu E, Tucureanu C, Raşid O, Vlase E, et al. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant. Hum Vaccin Immunother. 2016;12:1009-26 pubmed publisher